Puma Biotechnology (NASDAQ:PBYI) PT Set at $147.00 by Credit Suisse Group

Puma Biotechnology Inc logo Credit Suisse Group set a $147.00 target price on Puma Biotechnology (NASDAQ:PBYI) in a report published on Monday, January 22nd. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also …

Advertisements
Puma Biotechnology (NASDAQ:PBYI) PT Set at $147.00 by Credit Suisse Group

Hong Kong Seeks to Cash In on Frenzy For Chinese Biotech Stocks

The biotech proposal comes as a string of Chinese companies working on innovative drugs are seeking IPOs. The Hong Kong exchange aims to finalize the new rules and begin taking applications around June, and plans to add people with biotech expertise to its listing division, Chief Executive Officer …

Hong Kong Seeks to Cash In on Frenzy For Chinese Biotech Stocks

Puma Biotechnology (PBYI) Rating Increased to Hold at Zacks Investment Research

Puma Biotechnology logo Puma Biotechnology (NASDAQ:PBYI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday. According to Zacks, “Puma’s lead drug, Nerlynx (neratinib), was approved by the FDA in July …

Puma Biotechnology (PBYI) Rating Increased to Hold at Zacks Investment Research

Oprah pays her respects at grave of Recy Taylor

Oprah pays her respects at grave of Recy Taylor

Oprah Winfrey paid her respects at the grave of Recy Taylor, the Civil Rights icon she referenced in her now-iconic Golden Globes speech.

For more info, please go to http://www.globalnews.ca

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc

Like Global News on Facebook HERE: http://bit.ly/255GMJQ

Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt

[Read More …]

Oprah pays her respects at grave of Recy Taylor

Influential Analyst Rating Changes: Synergy Pharmaceuticals Inc. (SGYP), Cellect Biotechnology …

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) tinted gains of +5.73% (+0.13 points) to US$2.4. The volume of 5.4 Million shares climbed down over an trading activity of 7.33 Million shares. EPS ratio determined by looking at last 12 month figures is -1.16. Over the same time span, the stock marked …

Influential Analyst Rating Changes: Synergy Pharmaceuticals Inc. (SGYP), Cellect Biotechnology …